Search results for: "Novo Nordisk"

(167 records)

Novo Nordisk receives positive opinion on Levemir from EU committee

The EU\'s Committee for Proprietary Medicinal Products (CPMP) has adopted a positive opinion, recommending granting marketing authorisation to Novo Nordisk for Levemir (insulin...

BioStratum and Novo Nordisk sign development and marketing agreement

US drug discovery and development company BioStratum has signed a global research, development and marketing agreement with Novo Nordisk for the joint development of monoclonal...

Novo Nordisk to make insulin in Brazil

Novo Nordisk gets exclusive license option for Islet Neogenesis Therapy

Danish company Novo Nordisk, of Copenhagen, has signed an agreement with Canadian biopharmaceutical company Transition Therapeutics, granting it an exclusive option to license...

Novo Nordisk to build new insulin production plant in Brazil

Danish company Novo Nordisk is to invest more than US$200m (Euro 175m) in the construction of a new insulin production plant in the City of Montes Claros, Brazil.

Novo Nordisk disputes Pfizer's attempt to end US HRT agreement

Danish company Novo Nordisk claims Pfizer has attempted to terminate the license agreement under which Pfizer markets Novo Nordisk\'s portfolio of hormone replacement therapy...

New insulin device for better dose control from Novo Nordisk

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end track-and-trace capabilities for regulated industries where audit readiness and patient safety are critical
  2. Bausch and Lomb hit with FDA Warning Letter for persistent microbial contamination The regulator cited persistent out-of-limit microbial recoveries in ISO 5 areas, deficiencies in aseptic processing and airflow controls and an ineffective quality system at Bausch and Lomb's Tampa manufacturing facility
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Japanese researchers report advances in liver disease treatment and cancer screening Two research teams in Japan have published findings that could open new avenues in metabolic disease treatment and non-invasive cancer screening
  4. FDA approves Telix’s first FET-PET imaging drug for glioma Telix’s Pixclara is the first FDA-approved FET-PET imaging agent for glioma, enabling US clinicians to distinguish recurrent or progressive brain tumours from treatment-related changes
  5. Exceptional excipients enabled with expertise Growing regulatory expectations, increasing pressure to secure resilient regional supply chains and the need for more efficient manufacturing are reshaping how medicines are developed and produced

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing The platform supports pharmaceutical companies in developing, evaluating and optimising formulations and processes for continuous manufacturing
DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

Read more
Manufacturing Enzene is a CIDMO partner supporting innovators and biosimilar developers from discovery to commercial supply with integrated, paradigm-changing biologics services and...
Enzene: Bringing the most advanced innovations to biologics manufacturing

Enzene: Bringing the most advanced innovations to biologics manufacturing

Read more
Research & Development The collaboration combines human-relevant in vitro immunology with in vivo pharmacology to support biotech drug discovery programmes, including endometriosis research
Oncodesign Services and Nexus BioQuest partner on preclinical drug development

Oncodesign Services and Nexus BioQuest partner on preclinical drug development

Read more
Manufacturing UK CDMO Upperton can now manufacture sterile investigational medicinal products at its new 7,000 sq ft facility in Nottingham, expanding its GMP clinical supply capabilities
Upperton gains MHRA licence for Annex 1-aligned sterile facility

Upperton gains MHRA licence for Annex 1-aligned sterile facility

Read more
Pharma 5.0 The next phase of AI adoption in pharma could be less about discovering new medicines and more about tackling the operational barriers that prevent AI projects from scaling,...
Beyond drug discovery: the untapped value of AI in pharma operations

Beyond drug discovery: the untapped value of AI in pharma operations

Read more
Manufacturing As demand for HPAPIs and highly potent drug products grows, the pharmaceutical industry faces increasing pressure to combine containment, product and operator protection,...
Beyond containment: integrated line design reduces risk and complexity

Beyond containment: integrated line design reduces risk and complexity

Read more
Manufacturing Free in-person workshop combines expert theory with hands-on laboratory sessions to build confidence in viscosity measurement
Anton Paar’s popular viscosity workshop returns to Luton this October

Anton Paar’s popular viscosity workshop returns to Luton this October

Read more
Manufacturing New spray drying, dry granulation and pharmaceutical development solutions showcased at CPHI Milan
Glatt presents integrated particle engineering solutions at CPHI Milan

Glatt presents integrated particle engineering solutions at CPHI Milan

Read more